glycine and abt-199
glycine has been researched along with abt-199 in 11 studies
Research
Studies (11)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 7 (63.64) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| DiNardo, C; Guerra, VA; Konopleva, M | 1 |
| Comenzo, R; Lentzsch, S; Premkumar, V | 1 |
| Eskazan, AE; Kucukyurt, S | 1 |
| Hosono, N | 1 |
| DiNardo, CD; Wei, AH | 1 |
| Emadi, A; Estey, E; Gale, RP; Karp, JE; Othus, M | 1 |
| Anderson, MA; Birkinshaw, RW; Blombery, P; Chen, X; Conway, T; Czabotar, PE; Gong, JN; Huang, DCS; McBean, M; Nguyen, T; Roberts, AW; Seymour, JF; Thijssen, R; Thompson, ER; Westerman, DA | 1 |
| Carraway, HE; Chandhok, NS; Griffiths, EA; Prebet, T | 1 |
| Dutta, R; Jeng, MY; Mannis, GN; Tan, IT; Zhang, TY | 1 |
| Gao, L; Lan, H; Li, S; Liang, S; Ma, X; Song, Y; Yu, S; Zheng, X | 1 |
| Bolleddula, J; Ke, A; Prakash, C; Yang, H | 1 |
Reviews
5 review(s) available for glycine and abt-199
| Article | Year |
|---|---|
Venetoclax-based therapies for acute myeloid leukemia.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Cytarabine; Daunorubicin; Glycine; Humans; Leukemia, Myeloid, Acute; Phenylurea Compounds; Proto-Oncogene Proteins c-bcl-2; Pyridines; Sulfonamides; Triazines | 2019 |
New drugs approved for acute myeloid leukaemia in 2018.
Topics: Aniline Compounds; Antineoplastic Agents; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Disease-Free Survival; Glycine; Humans; Leukemia, Myeloid, Acute; Phenylurea Compounds; Progression-Free Survival; Pyrazines; Pyridines; Remission Induction; Sulfonamides | 2019 |
[New therapeutic agents for acute myeloid leukemia].
Topics: Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cyclopentanes; Drug Approval; Flavonoids; Glycine; Humans; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Phenylurea Compounds; Piperidines; Pyridines; Pyrimidines; Sulfonamides; United States; United States Food and Drug Administration | 2019 |
Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?
Topics: Antineoplastic Agents; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Daunorubicin; Drug Approval; Gemtuzumab; Glycine; Humans; Leukemia, Myeloid, Acute; Phenylurea Compounds; Pyridines; Randomized Controlled Trials as Topic; Staurosporine; Sulfonamides; United States; United States Food and Drug Administration | 2020 |
Advances in non-intensive chemotherapy treatment options for adults diagnosed with acute myeloid leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Decitabine; Gemtuzumab; Glycine; Humans; Leukemia, Myeloid, Acute; Male; Molecular Targeted Therapy; Phenylurea Compounds; Precision Medicine; Pyridines; Recurrence; Remission Induction; Staurosporine; Sulfonamides | 2020 |
Trials
1 trial(s) available for glycine and abt-199
| Article | Year |
|---|---|
Improved outcomes of octogenarians and nonagenarians with acute myeloid leukemia in the era of novel therapies.
Topics: Aged, 80 and over; Aniline Compounds; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclopentanes; Disease-Free Survival; Female; Glycine; Humans; Leukemia, Myeloid, Acute; Male; Pyrazines; Pyridines; Pyrimidines; Retrospective Studies; Sulfonamides; Survival Rate | 2020 |
Other Studies
5 other study(ies) available for glycine and abt-199
| Article | Year |
|---|---|
Venetoclax in Immunoglobulin Light Chain Amyloidosis: Is This the Beginning or the End?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boron Compounds; Bortezomib; Bridged Bicyclo Compounds, Heterocyclic; Dexamethasone; Glycine; Humans; Immunoglobulin Light Chains; Immunoglobulin Light-chain Amyloidosis; Male; Remission Induction; Sulfonamides | 2019 |
How I treat acute myeloid leukemia in the era of new drugs.
Topics: Adult; Aged; Aminopyridines; Aniline Compounds; Antineoplastic Agents; Biomarkers, Tumor; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Daunorubicin; Female; fms-Like Tyrosine Kinase 3; Glycine; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Molecular Targeted Therapy; Mutation; Prognosis; Pyrazines; Pyridines; Sialic Acid Binding Ig-like Lectin 3; Staurosporine; Sulfonamides; Triazines | 2020 |
Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax.
Topics: Amino Acid Substitution; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cohort Studies; Disease Progression; DNA Mutational Analysis; Drug Resistance, Neoplasm; Gene Frequency; Glycine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Models, Molecular; Mutation; Mutation Rate; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tumor Cells, Cultured; Valine | 2020 |
Glycine ameliorates mitochondrial dysfunction caused by ABT-199 in porcine oocytes.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Glycine; In Vitro Oocyte Maturation Techniques; Mitochondria; Oocytes; Reactive Oxygen Species; Sulfonamides; Swine | 2021 |
PBPK modeling to predict drug-drug interactions of ivosidenib as a perpetrator in cancer patients and qualification of the Simcyp platform for CYP3A4 induction.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Caco-2 Cells; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Female; Glycine; HEK293 Cells; Humans; Leukemia, Myeloid, Acute; Membrane Transport Proteins; Midazolam; Models, Biological; Pyridines; Sulfonamides | 2021 |